Fideuram Asset Management (Ireland)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Fideuram Asset Management (Ireland)'s BMY Position: Q2 2026 in Review
Fideuram Asset Management (Ireland) increased its Bristol-Myers Squibb (BMY) stake by 9,248% in Q2 2026, buying an estimated $13.8M and bringing the position to 242,950 shares worth $13.6M. The position accounts for 0.26% of the portfolio, ranked #100.
Fideuram Asset Management (Ireland) first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 864 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Fideuram Asset Management (Ireland) held 242,950 shares of Bristol-Myers Squibb worth $13.6M as of Q2 2026.
- Fideuram Asset Management (Ireland) bought 240,351 Bristol-Myers Squibb shares in Q2 2026, an estimated $13.8M.
- Bristol-Myers Squibb made up 0.26% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #100 holding.
- Fideuram Asset Management (Ireland) first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 864 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.